HYXIM
Cefixime BP
Description:
HYXIM (Cefixime) is a broad spectrum cephalosporin antibiotic of third generation for oral administration. It is a bactericidal antibiotic and is stable to hydrolysis by many beta-lactamases. HYXIM kills bacteria by interfering the synthesis of the bacterial cell wall. HYXIM is highly active against Neisseria Gonorrhoeae, Haemophilus Influenzae, Moraxella catarrhalis including beta-lactamase producers, most of the Enterobacteriaceae, Beta-Haemolytic Streptococci (Group A & B) and Streptococcus Pneumoniae, HYXIM is more active than other oral cephalosporins against Escherichia coli, Klebsiella spp, Proteus mirabilis and Serratia marcescens. HYXIM is also active against Streptococcus pyogenes. 40-50% of an oral dose is absorbed from gastro-intestinal tract, whether taken with meals or not. The plasma half-life is usually about 3 to 4 hours and may be prolonged when there is renal impairment. About 65% is bound to plasma protein. HYXIM is mainly excreted unchanged in bile and urine.
Composition:
HYXIM-200 Capsule: Each capsule contains Cefixime Trihydrate BP equivalent to anhydrous Cefixime 200 mg.
HYXIM Powder for Suspension:
After preparation each 5 ml contains Cefixime Trihydrate BP equivalent to anhydrous Cefixime 100 mg.
Indication:
It is indicated for the treatment of the following acute infection, when caused by susceptible
Microorganisms:
- Urinary tract infections : Cystitis, Cystourethritis, Pyelonephritis, Gonococcal Urethritis.
- Upper respiratory tract infections : Otitis media, and other URTI
where the causative organism is known or suspected to be resistant
to other commonly used antibiotics.
- Lower respiratory tract infections : Bronchitis, etc.
- Typhoid fever
Dosage and administration:
HYXIM Capsule :
Adult : 1 or 2 capsules (200-400 mg) as a single dose or in two divided
doses daily for 7-14 days, according to the severity of the infection.
Children above 6 months: 8 mg per kg body weight as a single dose or in two divided doses for 7-14 days according to the severity of the infection or as following:
6 months-1 year : 3.75 ml or 75 mg
1-4 years : 5 ml or 100 mg
5-10 years : 10 ml or 200 mg
11-12 years : 15 ml or 300 mg
Above 12 years : Adult dose may be administered
Children under 6 months: Not recommended.
Side Effects:
HYXIM is generally well tolerated. The majority of adverse reactions observed in clinical trials was mild and self-limiting in nature. Gastro-intestinal disturbances : Diarrhoea (if severe diarrhoea occurs, HYXIM should be discontinued), changes in the color of stool, Nausea, Abdominal pain, Dyspepsia, Vomiting, Flatulence have been reported. Central nervous system disturbances : Headache, Dizziness, etc. Others : Hypersensitivity reactions which usually subsided upon discontinuation of therapy; infrequent and reversible haematological changes; elevation of serum amylase, etc.
Contraindications:
Patients with known Hypersensitivity to Cephalosporin Antibiotics, children under 6 months.
Cautions:
HYXIM should be prescribed with caution in individuals with a history of Gastro-Intestinal Disease, Particularly Colitis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance <20 ml/ min).
Use in pregnancy and lactation:
No data are available, so it is probably best to avoid using the drug during pregnancy and by the nursing mothers.
Drug Interaction:
No data are available
Storage:
Store at normal temperature and away from sun light.
Packing:
HYXIM-200 Capsule: Box containing 1x6's capsules in alu-alu blister pack.
HYXIM Powder for Suspension: Bottle containing dry powder for Preparation of 50 ml suspension.
|